\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ abdominal\\ mass\ \(13\)\
\-\ normal\\ lab\\ exams\ \(0\)\
\-\ chemotherapy\ \(327\)\
\-\ ct\\ \ \(2714\)\
\-\ massive\\ retroperitoneal\\ and\\ mesenteric\\ lymphadenopathy\\.\ \(0\)\
\-\ sporadic\\ burkitt\\'s\\ lymphoma\\ \\(diffuse\\ small\\ noncleaved\\ cell\\ lymphoma\\)\ \(0\)\
\-\ nhl\\(3rd\\ most\\ common\\ malg\\.\\ childhood\\)\ \(0\)\
\-\ undifferentiated\\/small\\ noncleaved\\ nhl\\(burkitt\\)\ \(0\)\
\-\ hodgkin\\ lymphoma\ \(0\)\
\-\ acute\\ lymphocytic\\ leukemia\ \(5\)\
\-\ history\\ of\\ enlarging\\ abdomen\\ with\\ vague\\ consitutional\\ symptoms\\ for\\ several\\ months\\.\ \(0\)\
\-\ most\\ common\\ type\\ pediatric\\ non\\-hogkin\\ lymphoma\ \(0\)\
\-\ arise\\ from\\ undifferentiated\\ small\\ noncleaved\\ b\\-cell\\ lymphocytes\\.\\ histopathology\\ is\\ described\\ as\\ a\\ \\"starry\\-sky\\"\\ pattern\\.\\ it\\ is\\ the\\ fastest\\ growing\\ human\\ tumor\\ with\\ doubling\\ time\\ of\\ 24\\ hrs\\.\\ typically\\ no\\ peripheral\\ leukemia\\.\\ occurs\\ as\\ endemic\\ form\\ \\(seen\\ in\\ regions\\ w\\/\\ endemic\\ malaria\\)ex\\.\\ sub\\-saharan\\ africa\\ were\\ it\\ is\\ 80\\-90\\%\\ of\\ childhood\\ neoplasms\\.\\ presumed\\ exposure\\ to\\ plasmodium\\ falciparum\\ has\\ synergistic\\ effect\\ on\\ t\\-cell\\ surveillance\\.\\ associated\\ with\\ epstein\\-barr\\ virus\\ infection\\(95\\%\\)\\.\\ see\\ destructive\\ bone\\ lesions\\ in\\ the\\ face\\/jaw\\.\\ non\\-endemic\\ form\\ more\\ common\\ europe\\/north\\ america\\ were\\ it\\ is\\ 35\\-45\\%ped\\ nhl\\;3\\%\\ childhood\\ neoplasm\\.\\ epstein\\-barr\\ isolated\\ in\\ minority\\ of\\ cases\\.\\ see\\ involvement\\ abdomen\\ w\\/\\ small\\ bowel\\ and\\ mesentery\\(ususally\\ intraabdominal\\ extranodal\\)with\\ well\\ defined\\ homogenous\\ tumor\\.\\ can\\ infiltrate\\ organs\\(kidneys\\,ovary\\,retroperitoneum\\)\\.\\ pleual\\ effusion\\/ascited\\ common\\.\\ demonstrate\\ dramatic\\ response\\ to\\ chemotherapy\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ noncleaved\\:\\ 0\\.12021161487227043\ \(0\)\
\-\ epstein\\-barr\\:\\ 0\\.0738397385764232\ \(0\)\
\-\ childhood\\:\\ 0\\.0655661623463731\ \(0\)\
\-\ nhl\\:\\ 0\\.06385235413398584\ \(0\)\
\-\ endemic\\:\\ 0\\.06016630769663889\ \(0\)\
\-\ burkitt\\:\\ 0\\.05920848482702229\ \(0\)\
\-\ lymphoma\\:\\ 0\\.044403611534354286\ \(0\)\
\-\ common\\:\\ 0\\.04065940385375267\ \(0\)\
\-\ w\\/\\:\\ 0\\.04030447081175106\ \(0\)\
\-\ \\-nhl\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ malg\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ \\-undifferentiated\\/small\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ consitutional\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ non\\-hogkin\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ starry\\-sky\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ fastest\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ doubling\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ sub\\-saharan\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ plasmodium\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ non\\-endemic\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ europe\\/north\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ 35\\-45\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ ususally\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ pleual\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ effusion\\/ascited\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ leukemia\\:\\ 0\\.03986092386475622\ \(0\)\
\-\ \\-hodgkin\\:\\ 0\\.0369198692882116\ \(0\)\
\-\ falciparum\\:\\ 0\\.0369198692882116\ \(0\)\
\-\ face\\/jaw\\:\\ 0\\.0369198692882116\ \(0\)\
\-\ form\\:\\ 0\\.03632033507601328\ \(0\)\
\-\ \\%\\:\\ 0\\.03624220060629105\ \(0\)\
\-\ synergistic\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ ped\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ extranodal\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ africa\\:\\ 0\\.0337692002856664\ \(0\)\
\-\ minority\\:\\ 0\\.032754911416056354\ \(0\)\
\-\ malaria\\:\\ 0\\.031225492158687203\ \(0\)\
\-\ t\\-cell\\:\\ 0\\.031225492158687203\ \(0\)\
\-\ 80\\-90\\:\\ 0\\.029604242413511145\ \(0\)\
\-\ \\-acute\\:\\ 0\\.02917101432349149\ \(0\)\
\-\ ex\\:\\ 0\\.02917101432349149\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.028775508064447716\ \(0\)\
\-\ intraabdominal\\:\\ 0\\.02841167757502255\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.02841167757502255\ \(0\)\
\-\ human\\:\\ 0\\.028074823156141997\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.027844961683098773\ \(0\)\
\-\ hrs\\:\\ 0\\.026932484845774242\ \(0\)\
\-\ small\\:\\ 0\\.02684420842337889\ \(0\)\
\-\ america\\:\\ 0\\.02623179993746852\ \(0\)\
\-\ it\\:\\ 0\\.02619338706181386\ \(0\)\
\-\ virus\\:\\ 0\\.025439284541355897\ \(0\)\
\-\ sporadic\\:\\ 0\\.025089461627100768\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.025089461627100768\ \(0\)\
\-\ dramatic\\:\\ 0\\.025089461627100768\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.02476464815445465\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.024177322102272806\ \(0\)\
\-\ surveillance\\:\\ 0\\.024177322102272806\ \(0\)\
\-\ mesentery\\:\\ 0\\.023781815843229036\ \(0\)\
\-\ destructive\\:\\ 0\\.023302904408420734\ \(0\)\
\-\ see\\:\\ 0\\.02318379282935262\ \(0\)\
\-\ homogenous\\:\\ 0\\.023081130934923314\ \(0\)\
\-\ infiltrate\\:\\ 0\\.023081130934923314\ \(0\)\
\-\ abdomen\\:\\ 0\\.023012584208142693\ \(0\)\
\-\ \\(\\:\\ 0\\.02298423674412283\ \(0\)\
\-\ \\)\\:\\ 0\\.022703472021786977\ \(0\)\
\-\ organs\\:\\ 0\\.022288615538810688\ \(0\)\
\-\ massive\\:\\ 0\\.022198603596555327\ \(0\)\
\-\ presumed\\:\\ 0\\.022023756865519894\ \(0\)\
\-\ exams\\:\\ 0\\.021938792624555562\ \(0\)\
\-\ 95\\:\\ 0\\.021855387448791033\ \(0\)\
\-\ histopathology\\:\\ 0\\.02169303252787249\ \(0\)\
\-\ growing\\:\\ 0\\.021459881189747263\ \(0\)\
\-\ ovary\\:\\ 0\\.020958299111706966\ \(0\)\
\-\ vague\\:\\ 0\\.020890957812683596\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.02069472066784174\ \(0\)\
\-\ exposure\\:\\ 0\\.020209411688633983\ \(0\)\
\-\ isolated\\:\\ 0\\.020209411688633983\ \(0\)\
\-\ enlarging\\:\\ 0\\.019770955933235974\ \(0\)\
\-\ neoplasms\\:\\ 0\\.019770955933235974\ \(0\)\
\-\ response\\:\\ 0\\.01946781332187837\ \(0\)\
\-\ 3rd\\:\\ 0\\.01922977702407239\ \(0\)\
\-\ arise\\:\\ 0\\.01922977702407239\ \(0\)\
\-\ lab\\:\\ 0\\.019003588344258464\ \(0\)\
\-\ pediatric\\:\\ 0\\.018704718446245824\ \(0\)\
\-\ tumor\\:\\ 0\\.018111202741916466\ \(0\)\
\-\ most\\:\\ 0\\.01793486492480069\ \(0\)\
\-\ mesenteric\\:\\ 0\\.017910550458024303\ \(0\)\
\-\ kidneys\\:\\ 0\\.017875984097182395\ \(0\)\
\-\ regions\\:\\ 0\\.01777383475240031\ \(0\)\
\-\ were\\:\\ 0\\.0176389666971811\ \(0\)\
\-\ described\\:\\ 0\\.016542584960875767\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.01651697669852006\ \(0\)\
\-\ defined\\:\\ 0\\.016366284847079603\ \(0\)\
\-\ occurs\\:\\ 0\\.01594204875711497\ \(0\)\
\-\ 24\\:\\ 0\\.015102077184663406\ \(0\)\
\-\ pattern\\:\\ 0\\.01484746517759672\ \(0\)\
\-\ involvement\\:\\ 0\\.01423608480285371\ \(0\)\
\-\ peripheral\\:\\ 0\\.014054242372791442\ \(0\)\
\-\ palpable\\:\\ 0\\.013766459284544503\ \(0\)\
\-\ effect\\:\\ 0\\.013752537513951113\ \(0\)\
\-\ typically\\:\\ 0\\.013711026225027146\ \(0\)\
\-\ neoplasm\\:\\ 0\\.013227984435963309\ \(0\)\
\-\ type\\:\\ 0\\.013093746492485955\ \(0\)\
\-\ cases\\:\\ 0\\.01294004938173242\ \(0\)\
\-\ several\\:\\ 0\\.012486785616919942\ \(0\)\
\-\ bowel\\:\\ 0\\.012181606967657996\ \(0\)\
\-\ diffuse\\:\\ 0\\.011759124638069612\ \(0\)\
\-\ as\\:\\ 0\\.011750704599037525\ \(0\)\
\-\ infection\\:\\ 0\\.011290984427603668\ \(0\)\
\-\ time\\:\\ 0\\.010970914669269602\ \(0\)\
\-\ months\\:\\ 0\\.010608824066773033\ \(0\)\
\-\ cell\\:\\ 0\\.0104920032344613\ \(0\)\
\-\ lesions\\:\\ 0\\.010398002301563397\ \(0\)\
\-\ is\\:\\ 0\\.010223468697904102\ \(0\)\
\-\ more\\:\\ 0\\.009714437769600756\ \(0\)\
\-\ abdominal\\:\\ 0\\.009708723809645978\ \(0\)\
\-\ symptoms\\:\\ 0\\.009680261258627905\ \(0\)\
\-\ bone\\:\\ 0\\.00965197582481759\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009546068352871896\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009362497736282923\ \(0\)\
\-\ \\;\\:\\ 0\\.00920645994751179\ \(0\)\
\-\ associated\\:\\ 0\\.00916573891776228\ \(0\)\
\-\ 3\\:\\ 0\\.009095343303211543\ \(0\)\
\-\ demonstrate\\:\\ 0\\.008938418824241094\ \(0\)\
\-\ can\\:\\ 0\\.008810101602132135\ \(0\)\
\-\ well\\:\\ 0\\.008786731604402959\ \(0\)\
\-\ \\'s\\:\\ 0\\.00856384826530475\ \(0\)\
\-\ seen\\:\\ 0\\.007675580068489501\ \(0\)\
\-\ has\\:\\ 0\\.00729409077497399\ \(0\)\
\-\ normal\\:\\ 0\\.0060891475209050045\ \(0\)\
\-\ from\\:\\ 0\\.005756525968882783\ \(0\)\
\-\ in\\:\\ 0\\.00574632586554893\ \(0\)\
\-\ ct\\:\\ 0\\.0054331984245092856\ \(0\)\
\-\ mass\\:\\ 0\\.005402095486125293\ \(0\)\
\-\ history\\:\\ 0\\.005364611535032197\ \(0\)\
\-\ no\\:\\ 0\\.003911109775926372\ \(0\)\
\-\ to\\:\\ 0\\.003882437349481693\ \(0\)\
\-\ for\\:\\ 0\\.0033141279483759776\ \(0\)\
\-\ on\\:\\ 0\\.0032904136925701274\ \(0\)\
\-\ \\.\\:\\ 0\\.0027431459711585757\ \(0\)\
\-\ \\,\\:\\ 0\\.0024610005956117033\ \(0\)\
\-\ with\\:\\ 0\\.0021273486561798134\ \(0\)\
\-\ of\\:\\ 0\\.0021182509235997894\ \(0\)\
\-\ a\\:\\ 0\\.001802726371902733\ \(0\)\
\-\ and\\:\\ 0\\.0016364455066565312\ \(0\)\
\-\ the\\:\\ 0\\.001256811679123871\ \(0\)\
